Boenning & Scattergood’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.29M	Buy	53,475 +23,215	+77%	+$363K	0.21%	122
2022 Q3	$495K	Sell	30,260 -200	-0.7%	-$3.24K	0.1%	224
2022 Q2	$429K	Sell	30,460 -23,015	-43%	-$430K	0.08%	248
2022 Q1	$1.29M	Hold	53,475	–	–	0.21%	122
2021 Q4	$1.25M	Sell	53,475 -400	-0.7%	-$8.04K	0.2%	126
2021 Q3	$894K	Sell	53,875 -5,000	-8%	-$96.4K	0.16%	155
2021 Q2	$1.44M	Buy	58,875 +25,000	+74%	+$564K	0.25%	108
2021 Q1	$874K	Hold	33,875	–	–	0.17%	149
2020 Q4	$1.81M	Hold	33,875	–	–	0.38%	68
2020 Q3	$1.4M	Buy	33,875 +400	+1%	+$17.3K	0.34%	78
2020 Q2	$1.62M	Hold	33,475	–	–	0.43%	57
2020 Q1	$1.41M	Buy	33,475 +3,875	+13%	+$160K	0.49%	52
2019 Q4	$1.27M	Buy	29,600 +3,000	+11%	+$131K	0.33%	76
2019 Q3	$957K	Hold	26,600	–	–	0.28%	104
2019 Q2	$711K	Sell	26,600 -25,050	-48%	-$640K	0.21%	127
2019 Q1	$1.39M	Buy	51,650 +2,350	+5%	+$54.9K	0.42%	68
2018 Q4	$797K	Buy	49,300 +3,000	+6%	+$58.3K	0.28%	104
2018 Q3	$961K	Sell	46,300 -400	-0.9%	-$6.29K	0.31%	92
2018 Q2	$713K	Buy	+46,700	New	+$833K	0.23%	125